

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in managing Peyronie&rsquo;s... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-381/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-381" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in managing Peyronie’s disease" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in managing Peyronie&rsquo;s disease.">
            <meta name="og:description" content="Read the latest article version by Asrit Babu, Oliver Kayes, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="22598">
            <meta name="article-id" content="20557">
            <meta name="dc.title" content="Recent advances in managing Peyronie&rsquo;s disease">
            <meta name="dc.description" content="Treating men with Peyronie&rsquo;s disease remains a challenging problem facing clinicians working across urology and sexual medicine fields. Patients can often be left disappointed by current treatment paradigms, and an overall lack of suitable molecular targets has limited the options for novel, effective medical therapy. Managing men with Peyronie&rsquo;s disease often involves careful counselling alongside multifaceted and possible combination treatments to help improve symptoms whilst ameliorating potential side effects of therapy. We review the latest medical literature and evidence in the contemporary management of Peyronie&rsquo;s disease.">
            <meta name="dc.subject" content="Peyronie, collagenase, traction therapy, fibrosis, treatment, Peyronie&rsquo;s disease, urology, erectile dysfunction, non-surgical treatment">
            <meta name="dc.creator" content="Babu, Asrit">
            <meta name="dc.creator" content="Kayes, Oliver">
            <meta name="dc.date" content="2020/05/20">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.20557.1">
            <meta name="dc.source" content="F1000Research 2020 9:381">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Peyronie">
            <meta name="prism.keyword" content="collagenase">
            <meta name="prism.keyword" content="traction therapy">
            <meta name="prism.keyword" content="fibrosis">
            <meta name="prism.keyword" content="treatment">
            <meta name="prism.keyword" content="Peyronie&rsquo;s disease">
            <meta name="prism.keyword" content="urology">
            <meta name="prism.keyword" content="erectile dysfunction">
            <meta name="prism.keyword" content="non-surgical treatment">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/05/20">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="381">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.20557.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-381">
            <meta name="citation_title" content="Recent advances in managing Peyronie&rsquo;s disease">
            <meta name="citation_abstract" content="Treating men with Peyronie&rsquo;s disease remains a challenging problem facing clinicians working across urology and sexual medicine fields. Patients can often be left disappointed by current treatment paradigms, and an overall lack of suitable molecular targets has limited the options for novel, effective medical therapy. Managing men with Peyronie&rsquo;s disease often involves careful counselling alongside multifaceted and possible combination treatments to help improve symptoms whilst ameliorating potential side effects of therapy. We review the latest medical literature and evidence in the contemporary management of Peyronie&rsquo;s disease.">
            <meta name="citation_description" content="Treating men with Peyronie&rsquo;s disease remains a challenging problem facing clinicians working across urology and sexual medicine fields. Patients can often be left disappointed by current treatment paradigms, and an overall lack of suitable molecular targets has limited the options for novel, effective medical therapy. Managing men with Peyronie&rsquo;s disease often involves careful counselling alongside multifaceted and possible combination treatments to help improve symptoms whilst ameliorating potential side effects of therapy. We review the latest medical literature and evidence in the contemporary management of Peyronie&rsquo;s disease.">
            <meta name="citation_keywords" content="Peyronie, collagenase, traction therapy, fibrosis, treatment, Peyronie&rsquo;s disease, urology, erectile dysfunction, non-surgical treatment">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Asrit Babu">
            <meta name="citation_author_institution" content="Department of Urology, Leeds Teaching Hospitals, Leeds, UK">
            <meta name="citation_author" content="Oliver Kayes">
            <meta name="citation_author_institution" content="Department of Urology, Leeds Teaching Hospitals, Leeds, UK">
            <meta name="citation_publication_date" content="2020/05/20">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="381">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.20557.1">
            <meta name="citation_firstpage" content="381">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-381/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-381.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=22598 /> <input type=hidden id=articleId name=articleId value=20557 /> <input type=hidden id=xmlUrl value="/articles/9-381/v1/xml"/> <input type=hidden id=xmlFileName value="-9-381-v1.xml"> <input type=hidden id=article_uuid value=bae09173-d9d3-433e-9804-0a132d168dd6 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in managing Peyronie’s disease"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.20557.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.20557.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-381"
  },
  "headline": "Recent advances in managing Peyronie’s disease",
  "datePublished": "2020-05-20T12:16:34",
  "dateModified": "2020-05-20T12:16:34",
  "author": [
    {
      "@type": "Person",
      "name": "Asrit Babu"
    },    {
      "@type": "Person",
      "name": "Oliver Kayes"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Treating men with Peyronie&rsquo;s disease remains a challenging problem facing clinicians working across urology and sexual medicine fields. Patients can often be left disappointed by current treatment paradigms, and an overall lack of suitable molecular targets has limited the options for novel, effective medical therapy. Managing men with Peyronie&rsquo;s disease often involves careful counselling alongside multifaceted and possible combination treatments to help improve symptoms whilst ameliorating potential side effects of therapy. We review the latest medical literature and evidence in the contemporary management of Peyronie&rsquo;s disease."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-381.html",
            "name": "Recent advances in managing Peyronie’s disease"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in managing Peyronie’s disease </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=22598 data-id=20557 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20557.1" data-recommended="" data-doi="10.12688/f1000research.20557.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-381/v1/pdf?article_uuid=bae09173-d9d3-433e-9804-0a132d168dd6" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-20557-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-20557-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-20557-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Babu A and Kayes O. Recent advances in managing Peyronie’s disease [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):381 (<a class=new-orange href="https://doi.org/10.12688/f1000research.20557.1" target=_blank>https://doi.org/10.12688/f1000research.20557.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-20557-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=20557 id=track-article-signin-20557 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20557?target=/articles/9-381.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22598 /> <input name=articleId type=hidden value=20557 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in managing Peyronie’s disease</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Asrit Babu,&nbsp;</span><span class=""><a href="mailto:o.kayes@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Oliver Kayes</span></a><a href="https://orcid.org/0000-0001-5818-228X" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5818-228X</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Asrit Babu,&nbsp;</span><span class=""><a href="mailto:o.kayes@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Oliver Kayes</span></a><a href="http://orcid.org/0000-0001-5818-228X" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5818-228X</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 20 May 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.20557.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Urology, Leeds Teaching Hospitals, Leeds, UK<br/> <p> <div class=margin-bottom> Asrit Babu <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Oliver Kayes <br/> <span>Roles: </span> Methodology, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=14436-63497></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=12781-63496></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Treating men with Peyronie’s disease remains a challenging problem facing clinicians working across urology and sexual medicine fields. Patients can often be left disappointed by current treatment paradigms, and an overall lack of suitable molecular targets has limited the options for novel, effective medical therapy. Managing men with Peyronie’s disease often involves careful counselling alongside multifaceted and possible combination treatments to help improve symptoms whilst ameliorating potential side effects of therapy. We review the latest medical literature and evidence in the contemporary management of Peyronie’s disease. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Peyronie, collagenase, traction therapy, fibrosis, treatment, Peyronie’s disease, urology, erectile dysfunction, non-surgical treatment </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Oliver Kayes (<a href="mailto:o.kayes@nhs.net">o.kayes@nhs.net</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Oliver Kayes </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Babu A and Kayes O. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Babu A and Kayes O. Recent advances in managing Peyronie’s disease [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):381 (<a href="https://doi.org/10.12688/f1000research.20557.1" target=_blank>https://doi.org/10.12688/f1000research.20557.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 20 May 2020, <b>9</b>(F1000 Faculty Rev):381 (<a href="https://doi.org/10.12688/f1000research.20557.1" target=_blank>https://doi.org/10.12688/f1000research.20557.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 20 May 2020, <b>9</b>(F1000 Faculty Rev):381 (<a href="https://doi.org/10.12688/f1000research.20557.1" target=_blank>https://doi.org/10.12688/f1000research.20557.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e142>Background</h2><p class="" id=d17944e145>Peyronie’s disease (PD) is a relatively common progressive fibrotic disorder that affects the tunica albuginea. Traditionally, men will present with a new penile curvature, which may be associated with pain in the acute phase. Prevalence is reported to be in the region of 0.4–20%, with manifestation typically in the fifth decade of life<sup><a href="#ref-1">1</a>–<a href="#ref-3">3</a></sup>. PD may also be frequently associated with erectile dysfunction, penile shortening, psychological distress, and a palpable plaque, which is typically found on the dorsal aspect of the penile shaft. In some men, the penile curvature is severe enough to impair penetrative sexual intercourse.</p><p class="" id=d17944e155>The natural history of PD is divided into the active and quiescent (chronic or stable) phases. During the active phase, patients may report penile pain with a changing deformity (1–6 months). In contrast, the stable phase is generally associated with a painless and stable penile deformity (6–18 months).</p><p class="" id=d17944e158>Observational studies have shown that the majority of patients with PD will eventually have a stable curvature (40–47%), with a similar proportion showing progression (40–48%) and a much smaller group spontaneously improving (12–13%)<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. PD affects men principally between the ages of 40 and 60 and is associated with diabetes mellitus, Dupuytren’s contracture, and plantar fascial contracture (Ledderhose disease). There may be a preceding history of trauma.</p><p class="" id=d17944e168>The most common hypothesis regarding aetiology of the disease involves repeated minor microvascular trauma during intercourse resulting in intratunical bleeding and subsequent inflammation and fibrosis. Interestingly, we have seen PD in sexually naïve men who have never had penetrative intercourse. This may not refute the hypothesis but points further to a multifactorial process. Transforming growth factor beta (TGF-β) is thought to exacerbate the erratic healing response. Histologically, there is excessive connective tissue, increased cellularity, and random orientation of collagen fibres within the Peyronie’s plaque. Subsequently, the dysfunctional tunical tissue restricts normal expansion of the underlying corpus cavernosum, creating the observed curvature. There may be flaccidity distal to the lesion with or without a waisting (hourglass) deformity or rotation observed in more severe cases.</p><p class="" id=d17944e172>Surgical correction has historically been the mainstay of treatment but can harbour significant morbidity and in some series is related to poorer patient-reported outcomes. Patient morbidity from surgery includes haematoma and infection in the early post-operative period, with penile shortening, recurrent/residual curvature, glans hypoesthesia, and delayed erectile dysfunction manifesting later. In the majority of published case series, the main reasons for poor patient-reported outcomes tend to relate to the presence of residual curvature, overt penile shortening, and erectile dysfunction, with dissatisfaction rates ranging from 27–45% in those undergoing plication or plaque excision and grafting<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. As a result of this, there has been extensive research into non-surgical interventions that can potentially stabilise or improve penile curvature without the morbidity associated with surgery.</p><p class="" id=d17944e182>The aim of this review is to summarise the most recent advances in PD treatments, including surgical techniques, non-surgical interventions, and basic science updates. A review of the literature from 2017 onwards (24 months) was conducted by performing a MEDLINE® search of publications using the keyword “Peyronie”. In the absence of any new data for specific treatments or to consolidate the evidence around newer therapies, we have included older key papers for the readership’s general information.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e188>Basic science</h2><p class="" id=d17944e191>The most accepted pathophysiological aetiology of PD is that of microtrauma. This results from repeated injury resulting in an inflammatory response that promotes the formation of fibrous plaques through mediators such as TGF-β. There are very few studies that are able to show a clear correlation between the histological findings of trauma and Peyronie’s plaques in human histological specimens<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. El-Sakka <i>et al.</i> verified that TGF-β is strongly expressed in PD histology in a rat model, leading to an inflammatory process and fibrosis<sup><a href="#ref-10">10</a></sup>. De Rose <i>et al.</i> conducted a prospective observational study comparing the histological and ultrastructural changes seen in patients undergoing plaque excision for PD (in the absence of trauma) and those undergoing plaque excision for a history of penile fracture. The results showed the two groups had very similar collagen deposition, cellular composition, and extracellular matrix, in keeping with the proposed aetiology of microtrauma being the underlying cause of PD<sup><a href="#ref-11">11</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e218>Stem cell therapy</h2><p class="" id=d17944e221>Stem cells are undifferentiated cells that are capable of self-renewal and differentiation, promoting the repair of tissues via their immunomodulatory and anti-inflammatory action. Adipose-derived stem cells (ADSCs) are used most widely owing to their abundant tissue source and ease of isolation. There is currently limited evidence for the clinical use of stem cells in PD, with all studies restricted to rat models. Milenkovic, Albersen, and Castiglione reviewed the current evidence, which was limited to only four pre-clinical studies using ADSCs<sup><a href="#ref-12">12</a></sup>. Overall, these data support positive effects through differing proposed mechanisms of action, including reducing collagen and elastin deposition, reducing fibrosis, and increasing myofibroblast apoptosis<sup><a href="#ref-13">13</a>–<a href="#ref-16">16</a></sup>. Further clinical studies are needed to confirm the efficacy of stem cell therapy for PD in humans.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e238>Pharmacotherapy</h2><p class="" id=d17944e241>No oral pharmacotherapy is recommended by the American Urological Association (AUA) or the International Consortium of Sexual Medicine (ICSM) because of the lack of robust evidence. In contrast, the European Association of Urology (EAU) suggest that potassium para-aminobenzoate (Potaba) may result in a significant reduction in curvature, plaque size, and pain<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>.</p><p class="" id=d17944e251>Generally, the EAU, AUA, and ICSM guidelines have similar recommendations but differ on a few key points. These comparative points are highlighted in <a href="#T1">Table 1</a>. Unfortunately, it is beyond the scope of this review to further delineate any methodological or reporting differences used between these different guidelines panels that might generate further discussion regarding monotherapy or combination treatments. Suffice to say, given the relative paucity of high-quality evidence in this area, it is reasonable to concur that current oral monotherapies are universally considered to be of limited clinical use as a medical tool to directly reverse or modify PD outcomes in patients, either for symptom relief or to modify or improve longer-term functional outcomes.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Non-operative management of PD: summary of EAU, AUA, and ICSM guidelines<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d17944e275 class=n-a></a><thead><a name=d17944e277 class=n-a></a><tr><a name=d17944e279 class=n-a></a><th align=center colspan=1 rowspan=2><a name=d17944e280 class=n-a></a>Therapy</th><th align=center colspan=3 rowspan=1><a name=d17944e283 class=n-a></a>EAU (2015)</th><th align=center colspan=3 rowspan=1><a name=d17944e286 class=n-a></a>AUA (2015)</th><th align=center colspan=3 rowspan=1><a name=d17944e289 class=n-a></a>ICSM (2016)</th></tr><tr><a name=d17944e292 class=n-a></a><th align=center colspan=1 rowspan=1><a name=d17944e294 class=n-a></a>Advised</th><th align=center colspan=1 rowspan=1><a name=d17944e297 class=n-a></a>Not<br class=br>advised</th><th align=center colspan=1 rowspan=1><a name=d17944e302 class=n-a></a>LoE</th><th align=center colspan=1 rowspan=1><a name=d17944e305 class=n-a></a>Advised</th><th align=center colspan=1 rowspan=1><a name=d17944e308 class=n-a></a>Not<br class=br>advised</th><th align=center colspan=1 rowspan=1><a name=d17944e314 class=n-a></a>LoE</th><th align=center colspan=1 rowspan=1><a name=d17944e317 class=n-a></a>Advised</th><th align=center colspan=1 rowspan=1><a name=d17944e320 class=n-a></a>Not<br class=br>advised</th><th align=center colspan=1 rowspan=1><a name=d17944e325 class=n-a></a>LoE</th></tr></thead><tbody><a name=d17944e329 class=n-a></a><tr><a name=d17944e331 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e332 class=n-a></a><b>NSAID</b></td><td align=center colspan=1 rowspan=1><a name=d17944e336 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e338 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e340 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17944e343 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e346 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e349 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17944e352 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e354 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e356 class=n-a></a>-</td></tr><tr><a name=d17944e359 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e360 class=n-a></a><b>Potaba</b></td><td align=center colspan=1 rowspan=1><a name=d17944e364 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e367 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e369 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e372 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e374 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e378 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e380 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e382 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e385 class=n-a></a>B</td></tr><tr><a name=d17944e388 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e389 class=n-a></a><b>Vitamin E</b></td><td align=center colspan=1 rowspan=1><a name=d17944e393 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e395 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e398 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e401 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e403 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e407 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e410 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e412 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e415 class=n-a></a>B</td></tr><tr><a name=d17944e418 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e419 class=n-a></a><b>Tamoxifen</b></td><td align=center colspan=1 rowspan=1><a name=d17944e423 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e425 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e428 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e431 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e433 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e437 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e440 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e442 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e445 class=n-a></a>B</td></tr><tr><a name=d17944e448 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e449 class=n-a></a><b>Carnitine</b></td><td align=center colspan=1 rowspan=1><a name=d17944e453 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e455 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e458 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e461 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e463 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e467 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e470 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e472 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e475 class=n-a></a>B</td></tr><tr><a name=d17944e479 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e480 class=n-a></a><b>Pentoxifylline</b></td><td align=center colspan=1 rowspan=1><a name=d17944e484 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e486 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e489 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e492 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e494 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e498 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e501 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e503 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e506 class=n-a></a>B</td></tr><tr><a name=d17944e509 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e510 class=n-a></a><b>Colchicine</b></td><td align=center colspan=1 rowspan=1><a name=d17944e514 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e516 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e519 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e522 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e524 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e528 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e531 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e533 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e535 class=n-a></a>-</td></tr><tr><a name=d17944e538 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e539 class=n-a></a><b>Collagenase (I/L)</b></td><td align=center colspan=1 rowspan=1><a name=d17944e543 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e546 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e548 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e551 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e554 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e557 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e560 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e563 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e565 class=n-a></a>B</td></tr><tr><a name=d17944e568 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e569 class=n-a></a><b>Verapamil (I/L)</b></td><td align=center colspan=1 rowspan=1><a name=d17944e573 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e576 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e578 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e581 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e584 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e587 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e590 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e593 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e595 class=n-a></a>C</td></tr><tr><a name=d17944e598 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e599 class=n-a></a><b>Interferon (I/L)</b></td><td align=center colspan=1 rowspan=1><a name=d17944e603 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e606 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e608 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e611 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e614 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e617 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e620 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e623 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e625 class=n-a></a>B</td></tr><tr><a name=d17944e628 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e629 class=n-a></a><b>Steroids (I/L)</b></td><td align=center colspan=1 rowspan=1><a name=d17944e633 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e635 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e638 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e641 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e643 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e647 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17944e650 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e652 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e655 class=n-a></a></td></tr><tr><a name=d17944e658 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e659 class=n-a></a><b>Verapamil gel</b></td><td align=center colspan=1 rowspan=1><a name=d17944e663 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e666 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e668 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e671 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e673 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e677 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e679 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e681 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e684 class=n-a></a>B</td></tr><tr><a name=d17944e687 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e688 class=n-a></a><b>Verapamil and steroids (I/O)</b></td><td align=center colspan=1 rowspan=1><a name=d17944e692 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e695 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e697 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e700 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e702 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e706 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17944e709 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e711 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e714 class=n-a></a>B</td></tr><tr><a name=d17944e717 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e718 class=n-a></a><b>ESWT</b></td><td align=center colspan=1 rowspan=1><a name=d17944e722 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e725 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e728 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e731 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e733 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e737 class=n-a></a>B</td><td align=center colspan=1 rowspan=1><a name=d17944e740 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e742 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e745 class=n-a></a>B</td></tr><tr><a name=d17944e748 class=n-a></a><td align=center colspan=1 rowspan=1><a name=d17944e749 class=n-a></a><b>Mechanical</b></td><td align=center colspan=1 rowspan=1><a name=d17944e753 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e756 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e758 class=n-a></a>C</td><td align=center colspan=1 rowspan=1><a name=d17944e761 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e763 class=n-a></a>×</td><td align=center colspan=1 rowspan=1><a name=d17944e767 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17944e770 class=n-a></a>✓</td><td align=center colspan=1 rowspan=1><a name=d17944e773 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17944e775 class=n-a></a>C</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d17944e782 class=n-a></a><p id=d17944e784> AUA, American Urological Association; EAU, European Association of Urology; ESWT, extracorporeal shockwave therapy; ICSM, International Consortium of Sexual Medicine; I/L, intralesional; I/O, iontophoresis; LoE, level of evidence; NSAID, non-steroidal anti-inflammatory drug; PD, Peyronie’s disease; Potaba, potassium para-aminobenzoate.</p></div></div></div><div class=section><a name=d17944e790 class=n-a></a><h3 class=section-title>Potaba</h3><p class="" id=d17944e795>Two placebo-controlled randomised controlled studies (RCTs) have shown evidence that Potaba may reduce progression and pain<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. Weidner <i>et al.</i> demonstrated that penile plaque size was stabilised in the Potaba group compared to placebo. This subsequently reduced the progression of curvature in the treatment group when compared to placebo; however, it did not reduce any established curvature. This group did not demonstrate any evidence of improvement in pain relief. This is in contrast to the earlier RCT by Shah <i>et al.</i>, which demonstrated no evidence of improvement in curvature/plaque; however, it did show there was some improvement with regard to pain. Based on these two RCTs, Potaba currently is the only oral medication that has any recommendation for use within the EAU guidelines.</p><p class="" id=d17944e811>More recently, Potaba monotherapy was compared to combination therapy (tamoxifen, L-carnitine, and tadalafil) by Park <i>et al.</i><sup><a href="#ref-22">22</a></sup>. Perhaps the most striking result was that two-thirds of the patients in the Potaba arm withdrew for various reasons, although treatment side effects were cited as the largest single factor. The study failed to show any statistically significant difference between the two treatment arms owing to the high dropout rate. Overall, the most clinically relevant conclusions from this study showed that the side effect profile of Potaba may lead to very poor compliance and a high discontinuation rate.</p><p class="" id=d17944e820>The potential adverse effects of treatment alongside the limited evidence of efficacy therefore limit the recommendation of Potaba use, which is why it is not recommended by the AUA or ICSM at the time of writing.</p></div><div class=section><a name=d17944e825 class=n-a></a><h3 class=section-title>Vitamin E and antioxidant therapy</h3><p class="" id=d17944e830>Vitamin E is a fat-soluble, naturally occurring antioxidant that has previously been shown to improve pain, curvature, and erectile function scores (IIEF) and has been utilised in combination therapy with verapamil injections, non-steroidal anti-inflammatories, and herbal antioxidants, as reported in two recent randomised trials<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>.</p><p class="" id=d17944e840>The same authors have performed a further study in combination therapies using vitamin E. This case series was not randomised or controlled. A total of 141 patients were included in the study and assigned to one of five treatment groups that used varying amounts of antioxidant, analgesia, and injectable therapies including vitamin E, silymarin, Gingko biloba, topical diclofenac, and pentoxifylline injections. Throughout all groups, there was prevention in progression of disease. As the number of treatments increased, there was an improved outcome, particularly in IIEF score, reduced curvature, and improved quality of life/bother scores. The curvature improvement was minimal (4–6°) and likely clinically insignificant. In view of the study design not being randomised or controlled, the results must obviously be taken with caution<sup><a href="#ref-25">25</a></sup>.</p></div><div class=section><a name=d17944e848 class=n-a></a><h3 class=section-title>Phosphodiesterase-5 inhibitors and tamoxifen</h3><p class="" id=d17944e853>A recent scientific study has investigated a new model to test potential medical therapies in PD. The team describe an <i>in vitro</i> model that mimics the cellular changes seen in PD. It is well understood that myofibroblasts play a large role in the remodelling of the extracellular matrix and the production of profibrotic mediators and inflammatory cytokines<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. These cell lines have also been isolated in PD plaques<sup><a href="#ref-28">28</a></sup>. The authors were able to create a screening assay to assess the effectiveness of multiple treatments on the transformation of fibroblasts to myofibroblasts. Using this innovative model, they assessed the efficacy of 21 commonly studied oral therapies. The only compounds that proved to be effective on the fibroblast model included phosphodiesterase (PDE)-5 inhibitors and tamoxifen. These medications were then tested further in separate testing systems. The authors noted that each medication has the potential to prevent progression of disease in the active phase but is unlikely to reduce the plaque or curvature. They also identified that there was a synergistic effect with the two medications combined compared to either medication alone<sup><a href="#ref-29">29</a></sup>.</p></div><div class=section><a name=d17944e875 class=n-a></a><h3 class=section-title>Pentoxifylline</h3><p class="" id=d17944e880>Pentoxifylline is a non-specific PDE inhibitor that also has some effect in reducing TGF-β tissue levels and therefore may have an antifibrotic role and thereby a therapeutic role in PD<sup><a href="#ref-30">30</a></sup>. The evidence of its efficacy is limited as a monotherapy; however, there is some evidence to suggest its benefit as a combination treatment.</p><p class="" id=d17944e887>Smith <i>et al.</i> investigated the effect of pentoxifylline monotherapy on plaque calcification and subjective improvement of the clinical condition. They studied 71 men in a cohort study, of whom 62 were treated with pentoxifylline and nine received no treatment. The study showed that 92% of patients treated with pentoxifylline compared to 44% with no treatment had stable or improved plaque calcification. There were no objective outcomes to suggest improvement in curvature; however, there was subjective patient-reported improvement, which makes it somewhat difficult to make any firm conclusions regarding its true clinical benefit<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d17944e897>A further cohort study conducted by Alizadeh <i>et al.</i> compared pentoxifylline with intralesional verapamil and a combination of both therapies. A total of 90 patients were enrolled into three treatment arms (n = 30) with no control group. They reported improvement in curvature, plaque size, pain, and erectile dysfunction in all groups. Outcome measures were not quantitative and therefore no conclusions about degree of curvature change can be made<sup><a href="#ref-32">32</a></sup>. Recently, an older double blind RCT conducted by Safarinejad in 2010 using pentoxifylline monotherapy has since been redacted because of statistical incongruities<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d17944e911>A study exploring pentoxifylline as part of a combination therapy has been recently completed by Ibrahim <i>et al.</i><sup><a href="#ref-34">34</a></sup>; a total of 46 patients were included in this retrospective cohort study, which aimed to assess the effect of colchicine or pentoxifylline with penile traction therapy (PTT) (Andropenis® extender) on plaque size, degree of curvature, and penile Doppler parameters. Patients were assigned to oral pentoxifylline (n = 27) and colchicine (n = 18) with all advised to use PTT for 1 hour daily for a total of 6 months. The study reported an improvement in curvature of 14° (55.8° versus 41.4°) and also reported improvement in peak systolic velocity and reduction in plaque size. They found no statistically significant difference in the colchicine or pentoxifylline arm. The study has significant limitations in that there was no control group; therefore, it is possible that the improvement may have been purely spontaneous. It must also be noted that all patients received PTT, which potentially could explain why these parameters improved rather than as a result of any efficacy from the oral therapies. The efficacy of the Andropenis® extender is discussed further in this paper.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e924>Intralesional injection therapy</h2><div class=section><a name=d17944e927 class=n-a></a><h3 class=section-title>Collagenase</h3><p class="" id=d17944e932>Collagenase clostridium histolyticum (CCH) has been studied for use in PD in the experimental field since 1982<sup><a href="#ref-35">35</a></sup>. Since 2013, CCH has been approved by the United States Food and Drug Administration as well as the European Medicines Agency. Treatment comes in the form of an injection of two collagenases, which act synergistically to cleave tropocollagen. Its use is recommended by the AUA for PD curvature between 30° and 90°, and the EAU guidelines currently advise a grade B recommendation; however, these guidelines precede the largest published RCT<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d17944e943>IMPRESS I and II were large RCTs comparing CCH and penile modelling against penile modelling and placebo with 417 and 415 patients included in the study, respectively. Exclusion criteria included any patients with an hourglass deformity, significant erectile dysfunction non-responsive to PDE-5 inhibitors, proximal plaques, and curvature outside 30–90°. The treatment protocol involved two injections of CCH (0.58 mg) 24 to 72 hours apart. This cycle regimen was then repeated up to four times, alongside penile modelling by the clinician at the time of injection as well as by the patient three times daily thereafter until review. Curvature improved by 17° and 9° (34% versus 18.2%) in the treatment and placebo arms, respectively. There was also similar improvement in IIEF scores (+1 and +0.4, respectively) as well as penile length (0.4 cm and 0.2 cm, respectively). PD questionnaire (PDQ) bother scores were also improved in the treatment group; however, one-third of the cohort did not complete the questionnaire at one or both measurement points, and the PDQ is still not validated psychometrically<sup><a href="#ref-18">18</a>,<a href="#ref-36">36</a></sup>.</p><p class="" id=d17944e953>Ralph <i>et al.</i> conducted a randomised study comparing CCH, modelling, and vacuum therapy to CCH and vacuum therapy alone. This small pilot study (n = 30) did not show any statistically significant difference between the two groups in terms of curvature improvement or patient-reported outcome measures. There was a clear improvement in curvature of 23.7° in the CCH, modelling, and vacuum therapy group compared to 23.3° in the group without penile modelling. The injection protocol was similar to that in the IMPRESS trial with the addition of vacuum therapy being initiated following the second injection twice daily throughout the remainder of the study. There was only clinician modelling performed, with no patient modelling performed in either arm of the study<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup>.</p><p class="" id=d17944e966>A further study by this same group explored a modified injection protocol in a single-centre study of 53 patients alongside vacuum therapy during remodelling. The injection protocol consisted of three injections of 0.9 mg of CCH every 4 weeks. This was accompanied by manual modelling as well as vacuum therapy, and results showed equivalent outcomes to the IMPRESS trial with mean reduction in curvature of 17.3° (31.4%). This treatment regime reduced the need for multiple visits for injections and clinician modelling, which has the potential to lower costs and time for treatment<sup><a href="#ref-38">38</a></sup>. More recently, Capece and colleagues used the modified injection and remodelling protocol to perform a non-randomised, non-controlled multicentre study of 135 patients. They were able to reproduce the efficacy as described previously, with a mean reduction in curvature of 19° (42%). They did, however, note a slightly higher complication rate in the form of ecchymosis and haematoma when compared to the IMPRESS trial<sup><a href="#ref-39">39</a></sup>.</p><p class="" id=d17944e978>Ziegelmann <i>et al.</i> compared CCH and PTT versus CCH alone using a similar injection protocol to the IMPRESS trial with the addition of PTT for 3 hours per day. They found no significant difference in outcomes for CCH alone versus CCH and concomitant PTT. Overall curvature improvement was similar to that of the IMPRESS study, with a mean of 34% improvement. They reported poor adherence to the traction therapy with reducing compliance throughout the study, therefore likely limiting its effect. Ultimately, the authors felt that further RCT studies will be required to determine the role of traction therapy with CCH<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d17944e988>The latest published study in CCH treatment from an Italian group demonstrates a matched-pair comparison analysis of CCH in combination with sildenafil during the modelling phase. Using the same injection protocol as described in their previous study, they added sildenafil 25 mg BD 30–60 minutes prior to patient modelling. This was a small cohort study of 50 patients comparing the modified CCH protocol against CCH with the addition of sildenafil. They were able to show improved outcomes in curvature, IIEF scores, and PDQ scores, which were deemed to be statistically significant; however, the overall cohort was small. Curvature was improved by 25.6° in the CCH + sildenafil group compared to 17.4° in the group given CCH alone. This is clearly a promising outcome but needs further study in larger RCTs prior to any firm conclusions or recommendations being made<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d17944e995>CCH has clear robust RCT data showing definitive benefit in patients with PD and a penile curvature between 30° and 90°. There are numerous single-arm studies assessing variable treatment protocols that suggest that dosing adjustments can be made with associated accelerated treatment times and cost savings without compromising outcomes or safety parameters. It must also be noted that the IMPRESS studies showed a clear curvature improvement in the penile modelling group that is likely greater than placebo alone; this indicates that mechanical/modelling therapies alone may well have some efficacy, as outlined later in this article.</p><p class="" id=d17944e998>CCH clearly offers a less-invasive approach when compared to surgery; however, it is clear that the degree of curvature improvement is not as significant as is seen with surgery. Nevertheless, it does offer a treatment option for a select group of patients who may not be amenable to surgical intervention and would prefer conservative treatment if possible. The ‘real world’ paper by Anaissie <i>et al.</i> succinctly concluded that ultimately CCH needs further study to understand the optimal patient and which treatment regime produces the most efficacious result in terms of curvature improvement without being prohibitive on cost<sup><a href="#ref-42">42</a></sup>. We therefore eagerly await the results of larger, multicentre, and randomised studies to further focus on predictive factors for treatment success or failure and provide guidance for implementing CCH treatments in socially funded healthcare systems.</p><p class="" id=d17944e1008>The most recent unexpected update regarding CCH is its untimely removal from the European market by the manufacturers. This is an evolving situation, and the authors hope that an alternative product will be available in the near future<sup><a href="#ref-43">43</a></sup>. A summary of the salient studies and most recent clinical evidence in CCH can be found in <a href="#T2">Table 2</a>.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Summary of evidence showing the efficacy of CCH.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d17944e1029 class=n-a></a><thead><a name=d17944e1031 class=n-a></a><tr><a name=d17944e1033 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1034 class=n-a></a>Author</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1037 class=n-a></a>Year<br class=br>of<br class=br>study</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1044 class=n-a></a>Aim of study</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1047 class=n-a></a>Type of study</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1050 class=n-a></a>No. of<br class=br>patients</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1055 class=n-a></a>Injection protocol</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1059 class=n-a></a>Adjunct</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1062 class=n-a></a>Follow-<br class=br>up<br class=br>(weeks)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1069 class=n-a></a>Curvature<br class=br>improvement</th></tr></thead><tbody><a name=d17944e1075 class=n-a></a><tr><a name=d17944e1077 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1078 class=n-a></a><b>Gelbard <i>et al</i>.<sup><a href="#ref-36">36</a></sup></b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1088 class=n-a></a>2013</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1091 class=n-a></a>To assess<br class=br>efficacy of<br class=br>CCH alongside<br class=br>penile<br class=br>modelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1102 class=n-a></a>RCT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1105 class=n-a></a>832</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1108 class=n-a></a>Two 0.58 mg<br class=br>injections, 24–72<br class=br>hours apart<br class=br>Up to eight<br class=br>injections total</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1120 class=n-a></a>Clinician<br class=br>penile<br class=br>modelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1127 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1130 class=n-a></a>17°</td></tr><tr><a name=d17944e1133 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1134 class=n-a></a><b>Levine <i>et al</i>.<sup><a href="#ref-46">46</a></sup></b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1144 class=n-a></a>2015</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1147 class=n-a></a>To assess<br class=br>efficacy of<br class=br>CCH alongside<br class=br>penile<br class=br>modelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1158 class=n-a></a>Phase III open label</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1161 class=n-a></a>347</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1164 class=n-a></a>Two 0.58 mg<br class=br>injections, 24–72<br class=br>hours apart<br class=br>Up to eight<br class=br>injections total</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1176 class=n-a></a>Clinician<br class=br>penile<br class=br>modelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1183 class=n-a></a>36</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1186 class=n-a></a>18.3°</td></tr><tr><a name=d17944e1189 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1190 class=n-a></a><b>Ralph <i>et al</i>.<sup><a href="#ref-37">37</a></sup></b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1200 class=n-a></a>2017</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1203 class=n-a></a>Assess<br class=br>efficacy of<br class=br>CCH + vacuum<br class=br>therapy<br class=br>+/- penile<br class=br>modelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1216 class=n-a></a>Randomised<br class=br>pilot</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1221 class=n-a></a>30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1224 class=n-a></a>Two 0.58 mg<br class=br>injections, 24–72<br class=br>hours apart<br class=br>Up to eight<br class=br>injections total</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1236 class=n-a></a>Vacuum<br class=br>therapy<br class=br>+/- penile<br class=br>modelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1245 class=n-a></a>36</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1248 class=n-a></a>23.7° in CCH +<br class=br>vacuum therapy<br class=br>+ modelling 23.3°<br class=br>in CCH + vacuum<br class=br>therapy</td></tr><tr><a name=d17944e1259 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1260 class=n-a></a><b>Abdel Raheem</b><br class=br><b><i>et al</i>.<sup><a href="#ref-38">38</a></sup></b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1272 class=n-a></a>2017</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1275 class=n-a></a>To assess<br class=br>the safety<br class=br>and efficacy<br class=br>of modified<br class=br>injection<br class=br>protocol</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1288 class=n-a></a>Pilot</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1291 class=n-a></a>53</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1294 class=n-a></a>Three 0.9 mg<br class=br>injections 4<br class=br>weeks apart</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1302 class=n-a></a>Patient<br class=br>modelling<br class=br>and<br class=br>vacuum<br class=br>therapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1313 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1316 class=n-a></a>17°</td></tr><tr><a name=d17944e1319 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1320 class=n-a></a><b>Ziegelmann</b><br class=br><b><i>et al</i>.<sup><a href="#ref-40">40</a></sup></b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1332 class=n-a></a>2017</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1335 class=n-a></a>To compare<br class=br>efficacy of<br class=br>CCH + traction<br class=br>therapy against<br class=br>CCH alone</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1346 class=n-a></a>Prospective,<br class=br>non-<br class=br>randomised,<br class=br>non-controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1355 class=n-a></a>51</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1358 class=n-a></a>Two 0.58 mg<br class=br>injections, 24–72<br class=br>hours apart<br class=br>Up to eight<br class=br>injections total</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1370 class=n-a></a>Penile<br class=br>traction 3<br class=br>hours daily<br class=br>+ penile<br class=br>modelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1381 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1384 class=n-a></a>19.6° in CCH and<br class=br>traction<br class=br>23.6° in CCH<br class=br>alone</td></tr><tr><a name=d17944e1394 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1395 class=n-a></a><b>Capece <i>et al</i>.<sup><a href="#ref-39">39</a></sup></b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1405 class=n-a></a>2018</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1408 class=n-a></a>To assess<br class=br>efficacy of<br class=br>modified<br class=br>protocol</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1417 class=n-a></a>Multicentre,<br class=br>non-<br class=br>randomised,<br class=br>non-controlled<br class=br>prospective</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1428 class=n-a></a>135</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1431 class=n-a></a>Three 0.9 mg<br class=br>injections 4<br class=br>weeks apart</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1439 class=n-a></a>Patient<br class=br>modelling<br class=br>and<br class=br>vacuum<br class=br>therapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1450 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1453 class=n-a></a>19°</td></tr><tr><a name=d17944e1456 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1457 class=n-a></a><b>Cocci <i>et al</i>.<sup><a href="#ref-41">41</a></sup></b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1467 class=n-a></a>2018</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1470 class=n-a></a>To assess<br class=br>the efficacy<br class=br>of CCH +<br class=br>sildenafil</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1479 class=n-a></a>Prospective,<br class=br>non-<br class=br>randomised,<br class=br>non-controlled<br class=br>matched-pair<br class=br>comparison</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1492 class=n-a></a>50</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1495 class=n-a></a>Three 0.9 mg<br class=br>injections 4<br class=br>weeks apart</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1503 class=n-a></a>Sildenafil 25<br class=br>mg twice<br class=br>daily prior<br class=br>to patient<br class=br>modelling<br class=br>+ vacuum<br class=br>therapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1519 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1522 class=n-a></a>25.6° in CCH +<br class=br>sildenafil<br class=br>17.4° in CCH<br class=br>alone</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d17944e1535 class=n-a></a><p id=d17944e1537> CCH, collagenase clostridium histolyticum; RCT, randomised controlled trial</p></div></div></div></div><div class=section><a name=d17944e1544 class=n-a></a><h3 class=section-title>Verapamil</h3><p class="" id=d17944e1549>Intralesional verapamil injections are within the recommendations for treatment in the EUA, AUA, and ICSM guidelines. However, their use is supported by overall poor evidence and hence is given a grade C recommendation by all guidelines<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>.</p><p class="" id=d17944e1559>Verapamil is a calcium channel blocker that has been shown to interfere with fibroblast proliferation and can decrease collagen deposition by upgrading collagenase activity. There are only two trials comparing verapamil treatment and control subjects.</p><p class="" id=d17944e1562>Rehman <i>et al.</i> produced a small randomised control study comparing intralesional verapamil injections against placebo in a group of 14 patients. They used 10–27 mg injections weekly for 6 months. They were able to show a reduction in plaque length, curvature (7.9° in the treatment group compared to 2.2° in the placebo group), and penile pain<sup><a href="#ref-44">44</a></sup>. A further RCT by Shirazi <i>et al.</i> compared 10 mg verapamil injections to placebo. A total of 80 patients were enrolled and randomised 1:1 to either the treatment or the placebo arm. In the treatment group, patients were given 10 mg injections twice weekly for a total of 12 weeks. In contradiction to Rehman <i>et al.</i>, they were unable to find any significant improvement in curvature, plaque size, or penile pain reduction when compared to placebo<sup><a href="#ref-45">45</a></sup>.</p><p class="" id=d17944e1582>Favilla <i>et al.</i> recently compared intralesional injections of verapamil against hyaluronic acid (HA) in a double blinded randomised study. A total of 132 patients were included and given either weekly 10 mg intralesional verapamil or 16 mg/2 ml injections of HA. Outcomes showed a statistically significant improvement in plaque size (–1.36 mm and –1.8 mm) and IIEF score (1.46 and 1.78) in the verapamil and HA group, respectively. There was no improvement in curvature in the verapamil group in comparison to the HA group, which improved by 4.6°<sup><a href="#ref-47">47</a></sup>.</p><p class="" id=d17944e1593>There have been a number of further comparative randomised studies of verapamil over the past 10 years that have significant heterogeneity in their treatment regimens and also their comparative treatments. Greenfield <i>et al.</i> compared verapamil with saline in electromotive drug administration (EMDA) for PD. This study failed to show any statistically significant improvement in curvature<sup><a href="#ref-48">48</a></sup>. A randomised trial by Mehrsai <i>et al.</i> compared treatment in 60 patients treated with verapamil either via injection or EMDA. The authors found no significant difference in reduction of plaque size; however, they did note an improvement in erectile function (albeit not significant). Penile pain assessed by visual analogue scale was significantly reduced in the EMDA group compared with the injection group (–4.1 versus –1.8) at 3 months. Penile curvature was improved in both groups, and increased shift towards a ‘less-than-30°’ group was noted especially in the EMDA category. This improvement, however, was not quantified in more detail or statistically significant<sup><a href="#ref-49">49</a></sup>. Abern <i>et al.</i> compared verapamil, oral pentoxifylline, and L-arginine (group 1) against the same medical therapy and additional PTT (group 2). Both groups had improved penile curvature, and interestingly the PTT group (group 2) had less curvature improvement (11°) when compared to medical therapy and injections alone (15.1°). The authors did not complete any statistical comparison between the two groups<sup><a href="#ref-50">50</a></sup>.</p></div><div class=section><a name=d17944e1619 class=n-a></a><h3 class=section-title>Interferon α-2B</h3><p class="" id=d17944e1624>There have been no recent randomised placebo-controlled studies using interferon (IFN) α-2B. Kendirci <i>et al.</i> and Hellstrom <i>et al.</i> produced two placebo-controlled studies in 2005 and 2006, respectively. Kendirci <i>et al.</i> randomised 5 × 10<sup>6</sup> IU of IFN against placebo with a total of six injections given once weekly. They showed a statistically significant improvement in penile curvature with IFN of 12° compared to 3.6° in the placebo group. Hellstrom <i>et al.</i> produced similar results to Kendirci with a similar improvement in curvature<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>.</p><p class="" id=d17944e1650>More recently, Yafi <i>et al.</i> compared IFN with PTT versus IFN alone. This retrospective study had no placebo arm but did show a marginal improvement in curvature of 8.1° in the IFN and traction group compared to 9.9° in the IFN group, respectively. This difference in outcomes between groups was not statistically significant<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d17944e1660>The most recent publication regarding IFN injection therapy was a single-arm prospective non-randomised study performed by Sokhal <i>et al.</i> including 86 patients receiving 3 × 10<sup>6</sup> IU of IFN once weekly for a 12-week period. Follow-up was limited to only 3 months; however, there was a statistically significant improvement in plaque size, curvature, and IIEF-5 and pain scores. Plaque length reduced from 12.9 mm to 4.3 mm, and curvature improved by 16.2° (34.8° reduced to 18.6°) over the 3-month treatment period<sup><a href="#ref-54">54</a></sup>.</p></div><div class=section><a name=d17944e1674 class=n-a></a><h3 class=section-title>Hyaluronic acid</h3><p class="" id=d17944e1679>Gennaro and colleagues conducted a prospective RCT comparing intralesional HA compared with placebo in 2012. This study comprised 86 patients, with the treatment arm undergoing a total of 30 HA (20 mg) injections over 6 months every 5–7 days. There was a statistically significant improvement in curvature, plaque size, and IIEF when compared to placebo. At 24 months, the curvature was improved by 47% in the treatment arm, which equated to 9°. In the placebo arm, there was a deterioration in curvature of 19° over the same follow-up period<sup><a href="#ref-55">55</a></sup>.</p><p class="" id=d17944e1686>A single-arm, multicentre, pilot study was published by Zucchi <i>et al.</i> in 2016 and reported on outcomes from a 10-week cycle of HA (16 mg) intralesional injections in a total of 65 patients. They were able to demonstrate a statistically significant improvement in penile plaque length, curvature, IIEF, pain scores, and subjective outcome scores 2 months following the treatment regimen. Curvature was improved by 10° (from 30° to 20°) with no significant adverse events noted throughout the study<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d17944e1696>The comparative study by Favilla <i>et al.</i> described previously in this paper also showed advantageous outcomes of HA when compared to verapamil therapy<sup><a href="#ref-47">47</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e1711>Mechanical therapy for PD</h2><div class=section><a name=d17944e1714 class=n-a></a><h3 class=section-title>Penile traction devices</h3><p class="" id=d17944e1719>Mechanical therapy for PD as a treatment modality generally suffers from a lack of robust, randomised controlled studies<sup><a href="#ref-57">57</a></sup>. The purported mechanism of action of traction devices is likely to be secondary to cellular mechanotransduction. The mechanical strain on the cell body leads to multiple signal transduction pathways being activated, which is likely to lead to collagen degradation<sup><a href="#ref-58">58</a>,<a href="#ref-59">59</a></sup>. They currently have a grade C recommendation by the EAU and ICSM and are not recommended by the AUA owing to a lack of supportive evidence<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>.</p><p class="" id=d17944e1740>Gontero <i>et al.</i> described a regime of increasing mechanical traction (Andropenis® extender device) for a median of 5.5 hours a day over a 6-month period. They were able to produce a marginal non-statistically significant improvement of 4° from 31° to 27° following treatment. There was no improvement in IIEF or penile plaque length; however, there was a statistically significant improvement in stretched penile length of 0.8 cm<sup><a href="#ref-60">60</a></sup>.</p><p class="" id=d17944e1750>Using the same device (Andropenis® extender), Martínez-Salamanca and colleagues studied its use in the acute phase of PD over a 6-month period. This prospective non-randomised study compared traction to a non-intervention arm involving patients also considered to be in the acute phase over a 9-month period. In the treatment arm, the prescribed therapy was use of the device for 9 hours per day; however, because of poor adherence, average compliance was 4.6 hours. In the treatment arm, there was a reduction from 33° to 13°, resulting in a 20° curvature improvement. In contrast, the non-intervention arm had worsening curvature over the follow-up period, increasing by 23°. Outcomes were also improved in stretched penile length and IIEF scores in the treatment arm. There was, however, no statistical analysis comparing the two arms of the study, and potentially it is likely that the non-intervention group may have been on several oral therapies for PD<sup><a href="#ref-61">61</a></sup>.</p><p class="" id=d17944e1757>The first RCT of mechanical therapy has been published recently by Moncada <i>et al.</i> They conducted a study using the PeniMaster® PRO device compared to a control (non-intervention) group with promising results. A total of 93 patients were recruited and assigned to either arm of the study (47 in the treatment group and 43 controls). Follow-up was limited to 3 months, and treatment required use of the device for 3–8 hours daily. There was a clear reduction in penile curvature in the treatment group, which was directly correlated with adherence to device use. Overall reduction was significant at 31.2° (41.1%) compared to baseline, and there was no change in curvature in the control group. This reduction in curvature was enhanced when increasing the usage time. Greater than 6 hours’ use daily resulted in a 36.2° reduction compared to baseline (51.4%), whilst less than 4 hours produced a 19.7° improvement (28.8%). All of these results showed statistical significance. Furthermore, there was also increased stretched penile length and IIEF score. Outcomes overall are promising; however, 43% of patients noted adverse events, which were mainly glans numbness/oedema and local irritation. A total of 6.5% of patients (n = 3) in the treatment arm abandoned the study owing to these adverse events<sup><a href="#ref-62">62</a></sup>.</p><p class="" id=d17944e1768>More recently, Ziegelmann <i>et al.</i> published a further RCT using a novel mechanical device, RestoreX®. The newer device challenges some of the limitations seen with older, alternative traction devices, namely reduced usage times, increased comfort, and ability to bend the device to exert a focal, non-linear effect. The published trial studied 110 men using the device for only 30–90 minutes a day over a 3-month period. The study group was randomised 3:1 in favour of traction therapy. The results in this trial showed significant promise considering the observed shorter treatment times. A reduction in curvature of 11.7°, improvement in penile length of 1.5 cm, and improvement in IIEF score by 4.3 points were demonstrated<sup><a href="#ref-63">63</a></sup>. The control group showed no change in penile length, worsening IIEF, and an increase in curvature by 1.3°. Although this represents a relatively small study with short follow-up time, the results highlight potential positive efficacy and safety outcomes.</p><p class="" id=d17944e1778>Alom <i>et al.</i> continued to study the benefits of the RestoreX® device alongside CCH injections<sup><a href="#ref-64">64</a></sup>. They performed a comparative cohort study assessing three groups of therapy: CCH alone (group 1, n = 52), CCH plus other mechanical traction devices (group 2, n = 45), and CCH with RestoreX® device (group 3, n = 16). CCH protocol was the same across all patients and used the time schedule described in the IMPRESS trial. However, instead of two injections 24–72 hours per treatment, a single injection of 0.9 mg was used. Various mechanical devices were used in group 2, including the Andropenis® extender as well as the PeniMaster® PRO, which are described earlier in this review. All of these alternative devices required treatment for over 3 hours per day; however, compliance was very poor, with only 16% of this group reaching the required treatment time (median 1.5 hours). In comparison, the RestoreX® group saw a treatment compliance of 97% (median 0.9 hours). The study highlighted an improvement in curvature, which was statistically significant in all groups. Group 1 were able to achieve a 16.5° improvement, group 2 a 20° improvement, and group 3 a 30° improvement. The RestoreX® group also showed a greater improvement in length and various subjective assessments (improved penetration, feeling of meaningful improvement, and estimated percentage improvement) when compared to the other two groups. Overall, the study was able to show the largest degree of curvature change in the literature when compared to any other adjunctive treatment with CCH. It must be noted that these outcomes need to be reproduced in a RCT and in a larger cohort using the RestoreX® treatment group.</p><p class="" id=d17944e1788>The above trials on mechanical therapies have been tabularised in <a href="#T3">Table 3</a> with a brief outline of the clinical outcomes.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Summary of evidence showing the efficacy of mechanical therapies in PD.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d17944e1805 class=n-a></a><thead><a name=d17944e1807 class=n-a></a><tr><a name=d17944e1809 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1810 class=n-a></a>Author</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1813 class=n-a></a>Year of<br class=br>study</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1818 class=n-a></a>Aim of study</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1821 class=n-a></a>Type of<br class=br>study</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1826 class=n-a></a>No. of<br class=br>patients</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1831 class=n-a></a>Device</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1835 class=n-a></a>Usage protocol</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1838 class=n-a></a>Follow-<br class=br>up<br class=br>(weeks)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d17944e1845 class=n-a></a>Curvature<br class=br>improvement</th></tr></thead><tbody><a name=d17944e1851 class=n-a></a><tr><a name=d17944e1853 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1854 class=n-a></a>Gontero<br class=br><i>et al</i>.<sup><a href="#ref-60">60</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1864 class=n-a></a>2009</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1867 class=n-a></a>To assess<br class=br>efficacy of the<br class=br>Andropenis®<br class=br>extender for the<br class=br>treatment of PD</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1878 class=n-a></a>Prospective,<br class=br>non-<br class=br>controlled</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1885 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1888 class=n-a></a>Andropenis®<br class=br>extender<br class=br>device</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1896 class=n-a></a>5.5 hours daily<br class=br>for 6 months</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1901 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1904 class=n-a></a>4°</td></tr><tr><a name=d17944e1907 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1908 class=n-a></a>Martínez-<br class=br>Salamanca<br class=br><i>et al</i>.<sup><a href="#ref-61">61</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1920 class=n-a></a>2014</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1923 class=n-a></a>To assess<br class=br>efficacy of the<br class=br>Andropenis®<br class=br>extender for the<br class=br>treatment of PD in<br class=br>the acute phase</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1936 class=n-a></a>Prospective,<br class=br>controlled,<br class=br>non-<br class=br>randomised<br class=br>trial</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1947 class=n-a></a>96</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1950 class=n-a></a>Andropenis®<br class=br>extender<br class=br>device</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1958 class=n-a></a>6–9 hours daily<br class=br>for 6 months<br class=br>(4.6 hours/<br class=br>daily actual<br class=br>compliance)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1969 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1972 class=n-a></a>20°</td></tr><tr><a name=d17944e1975 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1976 class=n-a></a>Moncada <i>et al</i>.<sup><a href="#ref-62">62</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1985 class=n-a></a>2018</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1988 class=n-a></a>To assess the<br class=br>efficacy of the<br class=br>PeniMaster® PRO<br class=br>for the treatment<br class=br>of PD</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e1999 class=n-a></a>RCT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2002 class=n-a></a>93</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2005 class=n-a></a>PeniMaster®<br class=br>PRO</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2011 class=n-a></a>3–8 hours daily<br class=br>for 3 months</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2016 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2019 class=n-a></a>Mean<br class=br>improvement: 31<br class=br>° &gt;6 hours’ use: 36<br class=br>° &lt;4<br class=br>hours’ use: 20°</td></tr><tr><a name=d17944e2030 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2031 class=n-a></a>Ziegelmann<br class=br><i>et al</i>.<sup><a href="#ref-63">63</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2041 class=n-a></a>2019</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2044 class=n-a></a>To assess the<br class=br>efficacy of the<br class=br>RestoreX® device<br class=br>for the treatment<br class=br>of PD</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2055 class=n-a></a>RCT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2058 class=n-a></a>110</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2061 class=n-a></a>RestoreX®</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2065 class=n-a></a>30–90 minutes<br class=br>daily for 3<br class=br>months</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2072 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2075 class=n-a></a>11.7°</td></tr><tr><a name=d17944e2078 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2079 class=n-a></a>Alom <i>et al</i>.<sup><a href="#ref-64">64</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2088 class=n-a></a>2019</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2091 class=n-a></a>To assess the<br class=br>efficacy of CCH<br class=br>+/– traction<br class=br>therapy with either<br class=br>RestoreX® or other<br class=br>devices</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2104 class=n-a></a>Prospective<br class=br>comparative<br class=br>cohort study<br class=br><br class=br>Group 1 =<br class=br>CCH alone<br class=br><br class=br>Group 2 =<br class=br>CCH + other<br class=br>devices<br class=br><br class=br>Group 3<br class=br>= CCH +<br class=br>RestoreX®</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2132 class=n-a></a>113</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2135 class=n-a></a>RestoreX® or<br class=br>PeniMaster®<br class=br>PRO or<br class=br>Andropenis®<br class=br>extender</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2147 class=n-a></a>30–90 minutes<br class=br>daily for<br class=br>RestoreX®<br class=br><br class=br>&gt;3 hours daily<br class=br>for other devices<br class=br>(actual use 1.5<br class=br>hours)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2164 class=n-a></a>14</td><td align=left colspan=1 rowspan=1 valign=top><a name=d17944e2167 class=n-a></a>Group 1 = 16.5°<br class=br><br class=br>Group 2 = 20°<br class=br><br class=br>Group 3 = 30°</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d17944e2180 class=n-a></a><p id=d17944e2182> CCH, collagenase clostridium histolyticum; PD, Peyronie’s disease; RCT, randomised controlled trial</p></div></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e2192>External shockwave therapy</h2><p class="" id=d17944e2195>There has been limited research on external shockwave therapy (ESWT) for PD in recent times. Its use is not recommended by AUA, EAU, or ICSM guidelines for the treatment of curvature; however, it may have a use for those with penile pain secondary to PD<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>. A recent meta-analysis by Gao <i>et al.</i> reviewed the most recent RCTs using ESWT for PD. They found no statistically significant difference in curvature; however, they did note a statistically significant improvement in pain scores as well as plaque size in the six studies included comprising 443 patients. The authors, however, did note that pain in PD is usually self-limiting, so the role of ESWT in reducing the pain in these patients is arguable<sup><a href="#ref-65">65</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e2215>Surgery</h2><div class=section><a name=d17944e2218 class=n-a></a><h3 class=section-title>Surgical techniques and outcomes</h3><p class="" id=d17944e2223>There have been no significant advances in PD surgical management in terms of randomised controlled data. In keeping with historical trends, there have been numerous retrospective reviews of modifications to traditional plication and grafting techniques. Nevertheless, plication remains the standard of care for patients without erectile dysfunction and a curvature of less than 60° provided that the associated loss of length is not problematic. Incision and grafting are indicated in patients falling outside these criteria, although plaque excision without grafting has been reported previously as a simplified technique<sup><a href="#ref-66">66</a></sup>.</p><p class="" id=d17944e2230>Inflatable penile prosthesis (IPP) and manual remodelling have been re-assessed in a retrospective review by Chung <i>et al.</i> comparing choice of device manufacturer<sup><a href="#ref-67">67</a></sup>. They found high satisfaction (79%) and 5-year mechanical survival (87% or greater) in both AMS CX® and Coloplast Titan® devices as well as comparable revision and complication rates of below 10%. Further results regarding implant insertion and simultaneous plication demonstrated similar levels of satisfaction. Implant surgery remains the mainstay of treatment for patients with significant curvature and erectile dysfunction. Caution remains regarding a distinct lack of evidence to support universal surgical reconstruction in most men in order to provide safe and significant penile lengthening, as advocated by some surgeons globally.</p></div><div class=section><a name=d17944e2241 class=n-a></a><h3 class=section-title>Graft materials</h3><p class="" id=d17944e2246>Graft materials in those undergoing excision of the tunica albuginea in severe PD have been much debated and researched over recent years. The perfect graft material should be traction resistant, be easy to manipulate, and adhere to surrounding tissues with low risk of rejection. It should also be resistant to tension to prevent any aneurysmal dilation during normal erectile function. In addition, it should be economically viable and easily available. There has therefore been a large number of different grafting materials proposed and used in recent research for PD surgery including autografts, allografts, xenografts, and synthetics. Garcia-Gomez <i>et al.</i> recently reviewed the current evidence for all graft materials in tunica albuginea excision and grafting procedures. They concluded that the published series has significant heterogeneity in terms of patient selection, outcomes, and follow-up periods, therefore making definitive conclusions difficult. The authors did note that buccal mucosa, pericardium, porcine small intestinal submucosa (SIS), and TachoSil® are being used more extensively than most other materials, but unfortunately there is limited evidence to suggest one material over the other<sup><a href="#ref-68">68</a></sup>.</p><p class="" id=d17944e2256>Of note, TachoSil®, which is a fibrin-coated collagen fleece, is becoming an increasingly studied graft material because of its surgical advantages (no requirement to suture graft material). Two comparative studies have reviewed TachoSil® and SIS in penile grafting procedures. Falcone <i>et al.</i> compared the graft materials after plaque incision during penile prosthesis implantation in 60 patients. They noted a reduced operative time in the TachoSil® group of 120 minutes compared to 145 minutes in the SIS cohort. There was no difference in functional outcomes or complication rate at 35 months between the two groups<sup><a href="#ref-69">69</a></sup>. Rosenhammer <i>et al.</i> produced a similar study with a matched-pair analysis to aid in comparative outcome measure. They retrospectively matched 43 patients who underwent penile plaque excision/incision and grafting using SIS with a prospectively collected cohort who had similar demographics and preoperative penile curvature undergoing the same procedure using TachoSil® as the graft material. Once again, operative times were significantly reduced in the TachoSil® group compared to SIS: 80 minutes and 104 minutes, respectively. The TachoSil® group also showed no evidence of recurrence compared to SIS (9%). Shortening was 28% in the SIS group compared to only 5% in the TachoSil® group, which was statistically significant. Complication rates were similar in both groups at under 10%<sup><a href="#ref-70">70</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e2277>Future studies and directions</h2><p class="" id=d17944e2280>Over recent years, we have observed increasing interest and research into minimally invasive (or non-surgical) treatments for PD. The IMPRESS I and II studies have shaped the clinical landscape promoting the efficacy and safety of intralesional therapy using CCH alongside mechanical therapy devices. Accordingly, we have witnessed a rapid expansion in alternative therapeutic algorithms and improved understanding of the utility of CCH in certain men with PD. Future clinical research should continue to develop uniform research methodology and protocols, including a greater focus on patient-reported outcomes and cost-effectiveness analyses for newer treatments. Whilst multiple researchers have attempted to look into the efficacy of oral therapies for PD, we must concede that there is still no evidence to support their use as first-line treatments in either the acute or the chronic phases. We propose that developing better scientific models may translate into better drug screening and targeting opportunities to realise any meaningful future clinical outcome in RCTs or beyond. To better understand where PD lies among more systemic fibrotic conditions (e.g. normal/aberrant healing, retroperitoneal, liver, or lung fibrosis, etc.) requires careful collaborative efforts to share valuable clinical resources and data using ultimately expensively generated proteomic, genomic, and metabolomic data. This approach should focus on developing new biomarkers, compound screening, and application of improved imaging technology to effectively diagnose, prognose, and treat men with this debilitating heterogeneous and complex problem.</p><p class="" id=d17944e2283>Currently, the future favours an expansion of intralesional CCH usage, becoming the mainstay of treatment for PD if costs and drug availability allow. This depends a lot on engagement from existing pharmaceutical partners, particularly whilst drug patents restrict competition in the open marketplace. There is no doubt that urologists around the world are motivated to help develop and deliver a portfolio of minimally invasive treatments for PD in order to prevent or prolong the time without surgical intervention. Reversing this paradigm will be challenging, but the stepping stones already exist with ‘hotspots’ of high-quality basic scientific and clinical research evidence that will shape future treatments for men with PD. This needs to be matched with an increased general awareness of the problem through public health channels and reflected in a better financial infrastructure to incentivise and reward high-quality research and clinical care.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17944e2289>Conclusions</h2><p class="" id=d17944e2292>Intralesional treatments with modelling are demonstrating notable promise in treating PD non-surgically and at an earlier stage in the disease process. Generally, high treatment costs in non-insurance-based health systems, diverse experience, and the lack of widespread availability impede the current evidence base, particularly in terms of randomised trials.</p><p class="" id=d17944e2295>Whilst CCH outcomes and safety are supported by a large body of published evidence, the ideal treatment regime is still not clear, with a large number of studies being produced without control or comparative arms, thereby making the outcomes difficult to assess. IFN α-2B is the only other injectable therapy worthy of mention at this stage. These studies show a small improvement in curvature with a smaller cohort of patients in comparison to IMPRESS I and II, and the results have not been reproduced for over 10 years. Unfortunately, there has been no further robust research in other injectable intralesional therapies, which will likely limit their translational use.</p><p class="" id=d17944e2298>Penile traction and mechanical devices in PD are very likely to improve outcomes and may well have a further role in the primary treatment of PD or as an adjunct to injectable therapies. Newer penile traction devices show some promise, but further case-control studies will be needed to evaluate their potential as a non-surgical monotherapy<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d17944e2305>Within surgery, there is interest in novel graft materials, and further study into these materials is certainly warranted. In particular, outcomes using TachoSil® when compared to the more commonly used SIS materials have generated interesting data with respect to benefits observed with intraoperative technique and functional outcomes; however, further long-term results and comparative studies are required<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>.</p><p class="" id=d17944e2316>Currently, we seek to develop improved tools to assess patient depression, systemic health issues, and markers of poor quality of life. PD remains a difficult condition to successfully treat and should remain the remit of dedicated sexual health specialists and surgeons if we are to improve outcomes for men affected by PD and their partners.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d17944e2323 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d18450>References</h2><div class="section ref-list"><a name=d17944e2323 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d17944e2330 class=n-a></a>Schwarzer U, Sommer F, Klotz T, <i> et al.</i>: The prevalence of Peyronie's disease: results of a large survey. <i>BJU Int.</i> 2001; <b>88</b>(7): 727–30. <a target=xrefwindow id=d17944e2341 href="http://www.ncbi.nlm.nih.gov/pubmed/11890244">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2344 href="https://doi.org/10.1046/j.1464-4096.2001.02436.x">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d17944e2353 class=n-a></a>Mulhall JP, Creech SD, Boorjian SA, <i> et al.</i>: Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. <i>J Urol.</i> 2004; <b>171</b>(6 Pt 1): 2350–3. <a target=xrefwindow id=d17944e2364 href="http://www.ncbi.nlm.nih.gov/pubmed/15126819">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2367 href="https://doi.org/10.1097/01.ju.0000127744.18878.f1">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d17944e2376 class=n-a></a>Stuntz M, Perlaky A, des Vignes F, <i> et al.</i>: The Prevalence of Peyronie's Disease in the United States: A Population-Based Study. <i>PLoS One.</i> 2016; <b>11</b>(2): e0150157. <a target=xrefwindow id=d17944e2387 href="http://www.ncbi.nlm.nih.gov/pubmed/26907743">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2390 href="https://doi.org/10.1371/journal.pone.0150157">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2394 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4764365">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d17944e2403 class=n-a></a>Gelbard MK, Dorey F, James K: The natural history of Peyronie's disease. <i>J Urol.</i> 1990; <b>144</b>(6): 1376–9. <a target=xrefwindow id=d17944e2411 href="http://www.ncbi.nlm.nih.gov/pubmed/2231932">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2414 href="https://doi.org/10.1016/s0022-5347(17)39746-x">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d17944e2423 class=n-a></a>Mulhall JP, Schiff J, Guhring P: An analysis of the natural history of Peyronie's disease. <i>J Urol.</i> 2006; <b>175</b>(6): 2115–8. <a target=xrefwindow id=d17944e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/16697815">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2434 href="https://doi.org/10.1016/S0022-5347(06)00270-9">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d17944e2444 class=n-a></a>Baldini A, Morel-Journel N, Paparel P, <i> et al.</i>: Patient-reported long-term sexual outcomes following plication surgery for penile curvature: A retrospective 58-patient study. <i>Prog Urol.</i> 2017; <b>27</b>(1): 10–6. <a target=xrefwindow id=d17944e2455 href="http://www.ncbi.nlm.nih.gov/pubmed/27867021">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2458 href="https://doi.org/10.1016/j.purol.2016.08.018">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d17944e2467 class=n-a></a>Wimpissinger F, Parnham A, Gutjahr G, <i> et al.</i>: 10 Years' Plaque Incision and Vein Grafting for Peyronie's Disease: Does Time Matter? <i>J Sex Med.</i> 2016; <b>13</b>(1): 120–8. <a target=xrefwindow id=d17944e2478 href="http://www.ncbi.nlm.nih.gov/pubmed/26755094">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2481 href="https://doi.org/10.1016/j.jsxm.2015.12.004">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d17944e2490 class=n-a></a>Bilgutay AN, Pastuszak AW: Peyronie's Disease: A Review of Etiology, Diagnosis, and Management. <i>Curr Sex Health Rep.</i> 2015; <b>7</b>(2): 117–31. <a target=xrefwindow id=d17944e2498 href="http://www.ncbi.nlm.nih.gov/pubmed/26279643">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2501 href="https://doi.org/10.1007/s11930-015-0045-y">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2504 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4535719">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d17944e2513 class=n-a></a>Bjekic MD, Vlajinac HD, Sipetic SB, <i> et al.</i>: Risk factors for Peyronie's disease: a case-control study. <i>BJU Int.</i> 2006; <b>97</b>(3): 570–4. <a target=xrefwindow id=d17944e2524 href="http://www.ncbi.nlm.nih.gov/pubmed/16469028">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2527 href="https://doi.org/10.1111/j.1464-410X.2006.05969.x">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d17944e2536 class=n-a></a>El-Sakka AI, Selph CA, Yen TS, <i> et al.</i>: The effect of surgical trauma on rat tunica albuginea. <i>J Urol.</i> 1998; <b>159</b>(5): 1700–7. <a target=xrefwindow id=d17944e2547 href="http://www.ncbi.nlm.nih.gov/pubmed/9554397">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2550 href="https://doi.org/10.1097/00005392-199805000-00097">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737950867"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e2559 class=n-a></a>De Rose AF, Mantica G, Bocca B, <i> et al.</i>: Supporting the role of penile trauma and micro-trauma in the etiology of Peyronie's disease. Prospective observational study using the electronic microscope to examine two types of plaques. <i>Aging Male.</i> 2019; 1–6. <a target=xrefwindow id=d17944e2567 href="http://www.ncbi.nlm.nih.gov/pubmed/30879382">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2570 href="https://doi.org/10.1080/13685538.2019.1586870">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737950867">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734302958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e2584 class=n-a></a>Milenkovic U, Albersen M, Castiglione F: The mechanisms and potential of stem cell therapy for penile fibrosis. <i>Nat Rev Urol.</i> 2019; <b>16</b>(2): 79–97. <a target=xrefwindow id=d17944e2592 href="http://www.ncbi.nlm.nih.gov/pubmed/30367131">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2595 href="https://doi.org/10.1038/s41585-018-0109-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734302958">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d17944e2608 class=n-a></a>Gokce A, Abd Elmageed ZY, Lasker GF, <i> et al.</i>: Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease. <i>Andrology.</i> 2014; <b>2</b>(2): 244–51. <a target=xrefwindow id=d17944e2619 href="http://www.ncbi.nlm.nih.gov/pubmed/24574095">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2622 href="https://doi.org/10.1111/j.2047-2927.2013.00181.x">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725547313"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e2631 class=n-a></a>Gokce A, Abd Elmageed ZY, Lasker GF, <i> et al.</i>: Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis. <i>J Sex Med.</i> 2015; <b>12</b>(7): 1533–44. <a target=xrefwindow id=d17944e2642 href="http://www.ncbi.nlm.nih.gov/pubmed/26062100">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2645 href="https://doi.org/10.1111/jsm.12916">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2649 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4914049">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725547313">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962714"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e2662 class=n-a></a>Castiglione F, Hedlund P, van der Aa F, <i> et al.</i>: Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. <i>Eur Urol.</i> 2013; <b>63</b>(3): 551–60. <a target=xrefwindow id=d17944e2673 href="http://www.ncbi.nlm.nih.gov/pubmed/23040209">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2676 href="https://doi.org/10.1016/j.eururo.2012.09.034">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4029115">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962714">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d17944e2693 class=n-a></a>Jiang H, Gao Q, Che X, <i> et al.</i>: Inhibition of penile tunica albuginea myofibroblasts activity by adipose-derived stem cells. <i>Exp Ther Med.</i> 2017; <b>14</b>(5): 5149–5156. <a target=xrefwindow id=d17944e2704 href="http://www.ncbi.nlm.nih.gov/pubmed/29201230">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2707 href="https://doi.org/10.3892/etm.2017.5179">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2711 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5704342">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d17944e2720 class=n-a></a>Hatzimouratidis K, Eardley I, Giuliano F, <i> et al.</i>: EAU guidelines on penile curvature. <i>Eur Urol.</i> 2012; <b>62</b>(3): 543–52. <a target=xrefwindow id=d17944e2731 href="http://www.ncbi.nlm.nih.gov/pubmed/22658761">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2734 href="https://doi.org/10.1016/j.eururo.2012.05.040">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d17944e2744 class=n-a></a>Nehra A, Alterowitz R, Culkin DJ, <i> et al.</i>: Peyronie’s Disease: AUA Guideline. <i>J Urol.</i> 2015; <b>194</b>(3): 745–53. <a target=xrefwindow id=d17944e2755 href="http://www.ncbi.nlm.nih.gov/pubmed/26066402">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2758 href="https://doi.org/10.1016/j.juro.2015.05.098">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2762 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5027990">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d17944e2771 class=n-a></a>Chung E, Ralph D, Kagioglu A, <i> et al.</i>: Evidence-Based Management Guidelines on Peyronie's Disease. <i>J Sex Med.</i> 2016; <b>13</b>(6): 905–23. <a target=xrefwindow id=d17944e2782 href="http://www.ncbi.nlm.nih.gov/pubmed/27215686">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2785 href="https://doi.org/10.1016/j.jsxm.2016.04.062">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d17944e2794 class=n-a></a>Weidner W, Hauck EW, Schnitker J: Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. <i>Eur Urol.</i> 2005; <b>47</b>(4): 530–6. <a target=xrefwindow id=d17944e2802 href="http://www.ncbi.nlm.nih.gov/pubmed/15774254">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2805 href="https://doi.org/10.1016/j.eururo.2004.12.022">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d17944e2814 class=n-a></a>Shah PJR, Green NA, Adib RS, <i> et al.</i>: A multicentre double-blind controlled clinical trial of potassium para-amino-benzoate (POTABA1) in Peyronie’s disease. <i>Progr Reprod Biol Med J.</i> 1983; <b>9</b>: 61–7. </span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726561251"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e2832 class=n-a></a>Park TY, Jeong HG, Park JJ, <i> et al.</i>: The Efficacy of Medical Treatment of Peyronie's Disease: Potassium Para-Aminobenzoate Monotherapy vs. Combination Therapy with Tamoxifen, L-Carnitine, and Phosphodiesterase Type 5 Inhibitor. <i>World J Mens Health.</i> 2016; <b>34</b>(1): 40–6. <a target=xrefwindow id=d17944e2843 href="http://www.ncbi.nlm.nih.gov/pubmed/27169128">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2846 href="https://doi.org/10.5534/wjmh.2016.34.1.40">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4853769">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726561251">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726748009"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e2863 class=n-a></a>Paulis G, Brancato T, D'Ascenzo R, <i> et al.</i>: Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases. <i>Andrology.</i> 2013; <b>1</b>(1): 120–8. <a target=xrefwindow id=d17944e2874 href="http://www.ncbi.nlm.nih.gov/pubmed/23258640">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2877 href="https://doi.org/10.1111/j.2047-2927.2012.00007.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726748009">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d17944e2891 class=n-a></a>Paulis G, Cavallini G, Giorgio GD, <i> et al.</i>: Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie's disease (chronic inflammation of the tunica albuginea). Results of a controlled study. <i>Inflamm Allergy Drug Targets.</i> 2013; <b>12</b>(6): 403–9. <a target=xrefwindow id=d17944e2902 href="http://www.ncbi.nlm.nih.gov/pubmed/24304332">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2905 href="https://doi.org/10.2174/1871528112666131205112432">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d17944e2914 class=n-a></a>Paulis G, Paulis A, Romano G, <i> et al.</i>: Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application. <i>Res Rep Urol.</i> 2017; <b>9</b>: 129–39. <a target=xrefwindow id=d17944e2925 href="http://www.ncbi.nlm.nih.gov/pubmed/28791261">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2928 href="https://doi.org/10.2147/RRU.S141748">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2932 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5530853">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d17944e2941 class=n-a></a>Borthwick LA, Wynn TA, Fisher AJ: Cytokine mediated tissue fibrosis. <i>Biochim Biophys Acta.</i> 2013; <b>1832</b>(7): 1049–60. <a target=xrefwindow id=d17944e2949 href="http://www.ncbi.nlm.nih.gov/pubmed/23046809">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2952 href="https://doi.org/10.1016/j.bbadis.2012.09.014">Publisher Full Text </a> | <a target=xrefwindow id=d17944e2955 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3787896">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d17944e2964 class=n-a></a>Jalkut M, Gonzalez-Cadavid N, Rajfer J: New discoveries in the basic science understanding of Peyronie's disease. <i>Curr Urol Rep.</i> 2004; <b>5</b>(6): 478–84. <a target=xrefwindow id=d17944e2972 href="http://www.ncbi.nlm.nih.gov/pubmed/15541219">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2975 href="https://doi.org/10.1007/s11934-004-0074-y">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d17944e2984 class=n-a></a>Gelfand RA, Vernet D, Kovanecz I, <i> et al.</i>: The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets. <i>J Sex Med.</i> 2015; <b>12</b>(2): 313–27. <a target=xrefwindow id=d17944e2995 href="http://www.ncbi.nlm.nih.gov/pubmed/25496134">PubMed Abstract </a> | <a target=xrefwindow id=d17944e2998 href="https://doi.org/10.1111/jsm.12760">Publisher Full Text </a> | <a target=xrefwindow id=d17944e3002 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4339076">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734273270"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3011 class=n-a></a>Ilg MM, Mateus M, Stebbeds WJ, <i> et al.</i>: Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models. <i>Eur Urol.</i> 2019; <b>75</b>(2): 329–40. <a target=xrefwindow id=d17944e3022 href="http://www.ncbi.nlm.nih.gov/pubmed/30344087">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3025 href="https://doi.org/10.1016/j.eururo.2018.10.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734273270">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d17944e3039 class=n-a></a>Raetsch C, Jia JD, Boigk G, <i> et al.</i>: Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. <i>Gut.</i> 2002; <b>50</b>(2): 241–7. <a target=xrefwindow id=d17944e3050 href="http://www.ncbi.nlm.nih.gov/pubmed/11788567">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3053 href="https://doi.org/10.1136/gut.50.2.241">Publisher Full Text </a> | <a target=xrefwindow id=d17944e3057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1773098">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d17944e3066 class=n-a></a>Smith JF, Shindel AW, Huang YC, <i> et al.</i>: Pentoxifylline treatment and penile calcifications in men with Peyronie's disease. <i>Asian J Androl.</i> 2010; <b>13</b>(2): 322–5. <a target=xrefwindow id=d17944e3077 href="http://www.ncbi.nlm.nih.gov/pubmed/21102473">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3080 href="https://doi.org/10.1038/aja.2010.117">Publisher Full Text </a> | <a target=xrefwindow id=d17944e3084 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3565600">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d17944e3093 class=n-a></a>Alizadeh M, Karimi F, Fallah MR: Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline. <i>Glob J Health Sci.</i> 2014; <b>6</b>(7 Spec No): 23–30. <a target=xrefwindow id=d17944e3101 href="http://www.ncbi.nlm.nih.gov/pubmed/25363175">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3104 href="https://doi.org/10.5539/gjhs.v6n7p23">Publisher Full Text </a> | <a target=xrefwindow id=d17944e3107 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4796342">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1229973"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3116 class=n-a></a>Safarinejad MR, Asgari MA, Hosseini SY, <i> et al.</i>: A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie’s disease. <i>BJU Int.</i> 2010; <b>106</b>(2): 240–8. <a target=xrefwindow id=d17944e3127 href="http://www.ncbi.nlm.nih.gov/pubmed/19863517">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3130 href="https://doi.org/10.1111/j.1464-410X.2009.09041.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1229973">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737950870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3143 class=n-a></a>Ibrahim A, Gazzard L, Alharbi M, <i> et al.</i>: Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease. <i>Sex Med.</i> 2019; <b>7</b>(4): 459–63. <a target=xrefwindow id=d17944e3154 href="http://www.ncbi.nlm.nih.gov/pubmed/31445974">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3157 href="https://doi.org/10.1016/j.esxm.2019.07.003">Publisher Full Text </a> | <a target=xrefwindow id=d17944e3161 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6963116">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737950870">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d17944e3174 class=n-a></a>Gelbard MK, Walsh R, Kaufman JJ: Collagenase for Peyronie's disease experimental studies. <i>Urol Res.</i> 1982; <b>10</b>(3): 135–40. <a target=xrefwindow id=d17944e3182 href="http://www.ncbi.nlm.nih.gov/pubmed/6291216">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3185 href="https://doi.org/10.1007/BF00255956">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717985177"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3195 class=n-a></a>Gelbard M, Goldstein I, Hellstrom WJ, <i> et al.</i>: Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. <i>J Urol.</i> 2013; <b>190</b>(1): 199–207. <a target=xrefwindow id=d17944e3206 href="http://www.ncbi.nlm.nih.gov/pubmed/23376148">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3209 href="https://doi.org/10.1016/j.juro.2013.01.087">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717985177">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d17944e3222 class=n-a></a>Ralph DJ, Abdel Raheem A, Liu G: Treatment of Peyronie's Disease With Collagenase <i>Clostridium histolyticum</i> and Vacuum Therapy: A Randomized, Open-Label Pilot Study. <i>J Sex Med.</i> 2017; <b>14</b>(11): 1430–7. <a target=xrefwindow id=d17944e3233 href="http://www.ncbi.nlm.nih.gov/pubmed/28974406">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3236 href="https://doi.org/10.1016/j.jsxm.2017.08.015">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d17944e3245 class=n-a></a>Abdel Raheem A, Capece M, Kalejaiye O, <i> et al.</i>: Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol. <i>BJU Int.</i> 2017; <b>120</b>(5): 717–23. <a target=xrefwindow id=d17944e3256 href="http://www.ncbi.nlm.nih.gov/pubmed/28612401">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3259 href="https://doi.org/10.1111/bju.13932">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733183120"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3268 class=n-a></a>Capece M, Cocci A, Russo G, <i> et al.</i>: Collagenase clostridium histolyticum for the treatment of Peyronie's disease: A prospective Italian multicentric study. <i>Andrology.</i> 2018; <b>6</b>(4): 564–7. <a target=xrefwindow id=d17944e3279 href="http://www.ncbi.nlm.nih.gov/pubmed/29733116">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3282 href="https://doi.org/10.1111/andr.12497">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733183120">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d17944e3295 class=n-a></a>Ziegelmann MJ, Viers BR, Montgomery BD, <i> et al.</i>: Clinical Experience With Penile Traction Therapy Among Men Undergoing Collagenase <i>Clostridium histolyticum</i> for Peyronie Disease. <i>Urology.</i> 2017; <b>104</b>: 102–9. <a target=xrefwindow id=d17944e3309 href="http://www.ncbi.nlm.nih.gov/pubmed/28347795">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3313 href="https://doi.org/10.1016/j.urology.2017.01.054">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734068391"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3322 class=n-a></a>Cocci A, Cito G, Urzì D, <i> et al.</i>: Sildenafil 25 mg ODT + Collagenase <i>Clostridium hystoliticum</i> vs Collagenase <i>Clostridium hystoliticum</i> Alone for the Management of Peyronie’s Disease: A Matched-Pair Comparison Analysis. <i>J Sex Med.</i> 2018; <b>15</b>(10): 1472–7. <a target=xrefwindow id=d17944e3340 href="http://www.ncbi.nlm.nih.gov/pubmed/30245025">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3343 href="https://doi.org/10.1016/j.jsxm.2018.08.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734068391">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d17944e3357 class=n-a></a>Anaissie J, Hellstrom WJG, Yafi FA: Collagenase <i>Clostridium Histolyticum</i> for the Treatment of Peyronie’s Disease: A ‘Real World’ Clinical Perspective. <i>Drugs.</i> 2016; <b>76</b>(16): 1523–8. <a target=xrefwindow id=d17944e3368 href="http://www.ncbi.nlm.nih.gov/pubmed/27770352">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3371 href="https://doi.org/10.1007/s40265-016-0649-1">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d17944e3380 class=n-a></a>Cocci A, Russo GI, Salamanca JIM, <i> et al.</i>: The End of an Era: Withdrawal of Xiapex (<i>Clostridium histolyticum Collagenase</i>) from the European Market. <i>Eur Urol.</i> 2020; <b>77</b>(5): 660–1. <a target=xrefwindow id=d17944e3394 href="http://www.ncbi.nlm.nih.gov/pubmed/31810821">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3398 href="https://doi.org/10.1016/j.eururo.2019.11.019">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d17944e3407 class=n-a></a>Rehman J, Benet A, Melman A: Use of Intralesional Verapamil to Dissolve Peyronie’s Disease Plaque: A Long-Term Single-Blind Study. <i>Urology.</i> 1998; <b>51</b>(4): 620–6. <a target=xrefwindow id=d17944e3415 href="http://www.ncbi.nlm.nih.gov/pubmed/9586617">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3418 href="https://doi.org/10.1016/s0090-4295(97)00700-0">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d17944e3427 class=n-a></a>Shirazi M, Haghpanah AR, Badiee M, <i> et al.</i>: Effect of intralesional verapamil for treatment of Peyronie's disease: A randomized single-blind, placebo-controlled study. <i>Int Urol Nephrol.</i> 2009; <b>41</b>(3): 467–71. <a target=xrefwindow id=d17944e3438 href="http://www.ncbi.nlm.nih.gov/pubmed/19199072">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3441 href="https://doi.org/10.1007/s11255-009-9522-4">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d17944e3450 class=n-a></a>Levine LA, Cuzin B, Mark S, <i> et al.</i>: Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: A phase 3 open-label study. <i>J Sex Med.</i> 2015; <b>12</b>(1): 248–58. <a target=xrefwindow id=d17944e3461 href="http://www.ncbi.nlm.nih.gov/pubmed/25388099">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3464 href="https://doi.org/10.1111/jsm.12731">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d17944e3473 class=n-a></a>Favilla V, Russo GI, Zucchi A, <i> et al.</i>: Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: Preliminary results from a prospective, double-blinded, randomized study. <i>Andrology.</i> 2017; <b>5</b>(4): 771–5. <a target=xrefwindow id=d17944e3484 href="http://www.ncbi.nlm.nih.gov/pubmed/28718527">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3487 href="https://doi.org/10.1111/andr.12368">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d17944e3497 class=n-a></a>Greenfield JM, Shah SJ, Levine LA: Verapamil versus saline in electromotive drug administration for Peyronie's disease: A double-blind, placebo controlled trial. <i>J Urol.</i> 2007; <b>177</b>(3): 972–5. <a target=xrefwindow id=d17944e3505 href="http://www.ncbi.nlm.nih.gov/pubmed/17296390">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3508 href="https://doi.org/10.1016/j.juro.2006.10.065">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726748005"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3517 class=n-a></a>Mehrsai AR, Namdari F, Salavati A, <i> et al.</i>: Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease. <i>Andrology.</i> 2013; <b>1</b>(1): 129–32. <a target=xrefwindow id=d17944e3528 href="http://www.ncbi.nlm.nih.gov/pubmed/23258641">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3531 href="https://doi.org/10.1111/j.2047-2927.2012.00018.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726748005">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d17944e3544 class=n-a></a>Abern MR, Larsen S, Levine LA: Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. <i>J Sex Med.</i> 2012; <b>9</b>(1): 288–95. <a target=xrefwindow id=d17944e3552 href="http://www.ncbi.nlm.nih.gov/pubmed/22024053">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3555 href="https://doi.org/10.1111/j.1743-6109.2011.02519.x">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d17944e3564 class=n-a></a>Kendirci M, Usta MF, Matern RV, <i> et al.</i>: The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease. <i>J Sex Med.</i> 2005; <b>2</b>(5): 709–15. <a target=xrefwindow id=d17944e3575 href="http://www.ncbi.nlm.nih.gov/pubmed/16422829">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3578 href="https://doi.org/10.1111/j.1743-6109.2005.00110.x">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d17944e3587 class=n-a></a>Hellstrom WJG, Kendirci M, Matern R, <i> et al.</i>: Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease. <i>J Urol.</i> 2006; <b>176</b>(1): 394–8. <a target=xrefwindow id=d17944e3598 href="http://www.ncbi.nlm.nih.gov/pubmed/16753449">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3601 href="https://doi.org/10.1016/S0022-5347(06)00517-9">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725403953"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3610 class=n-a></a>Yafi FA, Pinsky MR, Stewart C, <i> et al.</i>: The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease. <i>J Urol.</i> 2015; <b>194</b>(3): 754–8. <a target=xrefwindow id=d17944e3621 href="http://www.ncbi.nlm.nih.gov/pubmed/25804087">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3624 href="https://doi.org/10.1016/j.juro.2015.03.092">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725403953">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733162287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3638 class=n-a></a>Sokhal A, Jain N, Jhanwar A, <i> et al.</i>: Prospective study to evaluate the clinical outcome of intralesional interferon-α 2b in the management of Peyronie's disease. <i>Urol Ann.</i> 2018; <b>10</b>(2): 154–158. <a target=xrefwindow id=d17944e3649 href="http://www.ncbi.nlm.nih.gov/pubmed/29719326">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3652 href="https://doi.org/10.4103/UA.UA_65_17">Publisher Full Text </a> | <a target=xrefwindow id=d17944e3656 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5907323">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733162287">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d17944e3670 class=n-a></a>Gennaro R, Barletta D, Paulis G: Intralesional hyaluronic acid: An innovative treatment for Peyronie's disease. <i>Int Urol Nephrol.</i> 2015; <b>47</b>(10): 1595–602. <a target=xrefwindow id=d17944e3678 href="http://www.ncbi.nlm.nih.gov/pubmed/26257044">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3681 href="https://doi.org/10.1007/s11255-015-1074-1">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726223993"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3690 class=n-a></a>Zucchi A, Costantini E, Cai T, <i> et al.</i>: Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study. <i>Sex Med.</i> 2016; <b>4</b>(2): e83–8. <a target=xrefwindow id=d17944e3701 href="http://www.ncbi.nlm.nih.gov/pubmed/26984291">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3704 href="https://doi.org/10.1016/j.esxm.2016.01.002">Publisher Full Text </a> | <a target=xrefwindow id=d17944e3708 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5005307">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726223993">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734054674"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3721 class=n-a></a>Russo GI, Milenkovic U, Hellstrom W, <i> et al.</i>: Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature. <i>Eur Urol.</i> 2018; <b>74</b>(6): 767–81. <a target=xrefwindow id=d17944e3732 href="http://www.ncbi.nlm.nih.gov/pubmed/30237020">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3735 href="https://doi.org/10.1016/j.eururo.2018.07.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734054674">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d17944e3748 class=n-a></a>Chung E, de Young L, Solomon M, <i> et al.</i>: Peyronie's Disease and Mechanotransduction: An In Vitro Analysis of the Cellular Changes to Peyronie's Disease in a Cell-Culture Strain System. <i>J Sex Med.</i> 2013; <b>10</b>(5): 1259–67. <a target=xrefwindow id=d17944e3759 href="http://www.ncbi.nlm.nih.gov/pubmed/3421851">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3762 href="https://doi.org/10.1111/jsm.12082">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734138200"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3771 class=n-a></a>Setia SA, Levine LA: Devices for penile traction: The long and winding road to treating Peyronie's disease. <i>Expert Rev Med Devices.</i> 2018; <b>15</b>(8): 517–26. <a target=xrefwindow id=d17944e3779 href="http://www.ncbi.nlm.nih.gov/pubmed/30016597">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3782 href="https://doi.org/10.1080/17434440.2018.1502083">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734138200">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d17944e3796 class=n-a></a>Gontero P, Di Marco M, Giubilei G, <i> et al.</i>: Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective Study. <i>J Sex Med.</i> 2009; <b>6</b>(2): 558–66. <a target=xrefwindow id=d17944e3807 href="http://www.ncbi.nlm.nih.gov/pubmed/19138361">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3810 href="https://doi.org/10.1111/j.1743-6109.2008.01108.x">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718184628"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3819 class=n-a></a>Martínez-Salamanca JI, Egui A, Moncada I, <i> et al.</i>: Acute phase Peyronie's disease management with traction device: A nonrandomized prospective controlled trial with ultrasound correlation. <i>J Sex Med.</i> 2014; <b>11</b>(2): 506–15. <a target=xrefwindow id=d17944e3830 href="http://www.ncbi.nlm.nih.gov/pubmed/24261900">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3833 href="https://doi.org/10.1111/jsm.12400">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718184628">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734297285"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3847 class=n-a></a>Moncada I, Krishnappa P, Romero J, <i> et al.</i>: Penile traction therapy with the new device ‘Penimaster PRO’ is effective and safe in the stable phase of Peyronie's disease: A controlled multicentre study. <i>BJU Int.</i> 2019; <b>123</b>(4): 694–702. <a target=xrefwindow id=d17944e3858 href="http://www.ncbi.nlm.nih.gov/pubmed/30365247">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3861 href="https://doi.org/10.1111/bju.14602">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734297285">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735406340"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3875 class=n-a></a>Ziegelmann M, Savage J, Toussi A, <i> et al.</i>: Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. <i>J Urol.</i> 2019; <b>202</b>(3): 599–610. <a target=xrefwindow id=d17944e3886 href="http://www.ncbi.nlm.nih.gov/pubmed/30916626">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3889 href="https://doi.org/10.1097/JU.0000000000000245">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735406340">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735506211"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3903 class=n-a></a>Alom M, Sharma KL, Toussi A, <i> et al.</i>: Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie’s Disease. <i>J Sex Med.</i> 2019; <b>16</b>(6): 891–900. <a target=xrefwindow id=d17944e3914 href="http://www.ncbi.nlm.nih.gov/pubmed/30956106">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3917 href="https://doi.org/10.1016/j.jsxm.2019.03.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735506211">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d17944e3931 class=n-a></a>Gao L, Qian S, Tang Z, <i> et al.</i>: A meta-analysis of extracorporeal shock wave therapy for Peyronie’s disease. <i>Int J Impot Res.</i> 2016; <b>28</b>(5): 161–6. <a target=xrefwindow id=d17944e3942 href="http://www.ncbi.nlm.nih.gov/pubmed/27250868">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3945 href="https://doi.org/10.1038/ijir.2016.24">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726748012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3955 class=n-a></a>Mantovani F, Patelli E, Antolini C: Peyronie's disease: Endocavernous plaque excision without substitutive graft: critical 5-year experience. <i>Urologia.</i> 2013; <b>80</b>(Suppl 22): 28–30. <a target=xrefwindow id=d17944e3963 href="http://www.ncbi.nlm.nih.gov/pubmed/23334885">PubMed Abstract </a> | <a target=xrefwindow id=d17944e3966 href="https://doi.org/10.5301/RU.2013.10599">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726748012">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718343018"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e3980 class=n-a></a>Chung PH, Francis Scott J, Morey AF: High Patient Satisfaction of Inflatable Penile Prosthesis Insertion with Synchronous Penile Plication for Erectile Dysfunction and Peyronie's Disease. <i>J Sex Med.</i> 2014; <b>11</b>(6): 1593–8. <a target=xrefwindow id=d17944e3988 href="https://doi.org/10.1111/jsm.12530">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718343018">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732337286"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e4002 class=n-a></a>Garcia-Gomez B, Ralph D, Levine L, <i> et al.</i>: Grafts for Peyronie's disease: A comprehensive review. <i>Andrology.</i> 2018; <b>6</b>(1): 117–26. <a target=xrefwindow id=d17944e4013 href="http://www.ncbi.nlm.nih.gov/pubmed/29266877">PubMed Abstract </a> | <a target=xrefwindow id=d17944e4016 href="https://doi.org/10.1111/andr.12421">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732337286">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733231738"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e4030 class=n-a></a>Falcone M, Preto M, Ceruti C, <i> et al.</i>: A Comparative Study Between 2 Different Grafts Used as Patches After Plaque Incision and Inflatable Penile Prosthesis Implantation for End-Stage Peyronie's Disease. <i>J Sex Med.</i> 2018; <b>15</b>(7): 1061–1062. <a target=xrefwindow id=d17944e4041 href="http://www.ncbi.nlm.nih.gov/pubmed/29861353">PubMed Abstract </a> | <a target=xrefwindow id=d17944e4044 href="https://doi.org/10.1016/j.jsxm.2018.04.646">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733231738">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736178162"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17944e4058 class=n-a></a>Rosenhammer B, Sayedahmed K, Fritsche HM, <i> et al.</i>: Long-term outcome after grafting with small intestinal submucosa and collagen fleece in patients with Peyronie's disease: A matched pair analysis. <i>Int J Impot Res.</i> 2019; <b>31</b>(4): 256–62. <a target=xrefwindow id=d17944e4069 href="http://www.ncbi.nlm.nih.gov/pubmed/30194372">PubMed Abstract </a> | <a target=xrefwindow id=d17944e4072 href="https://doi.org/10.1038/s41443-018-0071-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736178162">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 May 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-381.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-381.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Urology, Leeds Teaching Hospitals, Leeds, UK<br/> <p> <div class=margin-bottom> Asrit Babu <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Oliver Kayes <br/> <span>Roles: </span> Methodology, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-381/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 20 May 2020, 9:381 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.20557.1">https://doi.org/10.12688/f1000research.20557.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Babu A and Kayes O. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=22598 data-id=20557 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20557.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-381/v1/pdf?article_uuid=bae09173-d9d3-433e-9804-0a132d168dd6" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.20557.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Babu A and Kayes O. Recent advances in managing Peyronie’s disease [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):381 (<a href="https://doi.org/10.12688/f1000research.20557.1" target=_blank>https://doi.org/10.12688/f1000research.20557.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=20557 id=mobile-track-article-signin-20557 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20557?target=/articles/9-381.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22598 /> <input name=articleId type=hidden value=20557 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Wayne J. G. Hellstrom</strong>, Department of Urology, Tulane University Health Sciences Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Ayad A. Yousif</strong>, Department of Urology, Tulane University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Alexander W. Pastuszak</strong>, Division of Urology, Department of Surgery, University of Utah School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> This reviewer is associated with Endo Pharmaceuticals (maker of Xiaflex / CCH) - consultant, advisor, research funding and fellowship support. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 May 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-381.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-381.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=14436-63497></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=12781-63496></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-381/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>20 May 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Wayne J. G. Hellstrom</strong>, Department of Urology, Tulane University Health Sciences Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Ayad A. Yousif</strong>, Department of Urology, Tulane University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Alexander W. Pastuszak</strong>, Division of Urology, Department of Surgery, University of Utah School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> This reviewer is associated with Endo Pharmaceuticals (maker of Xiaflex / CCH) - consultant, advisor, research funding and fellowship support. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-381.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-381/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in managing Peyronie\u2019s...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-381/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-381/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-381/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Babu A and Kayes O');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-381/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-381",
            templates : {
                twitter : "Recent advances in managing Peyronie\u2019s disease. Babu A and Kayes O, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-381/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in managing Peyronie\u2019s disease", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in managing Peyronie\u2019s disease", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/20557/22598")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "22598");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "63496": 0,
                           "63497": 5,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "d2805f26-2bb1-43a7-a9de-f3637ee17fa3";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-381.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-381.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-381.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-381.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-381.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>